Research and Markets: Global Germinomatous (Seminomatous) Germ Cell Tumors Clinical Trials Review 2014

Research and Markets (http://www.researchandmarkets.com/research/zkbv4p/germinomatous) has announced the addition of the "Germinomatous (Seminomatous) Germ Cell Tumors Global Clinical Trials Review, H1, 2014" report to their offering.

Germinomatous (Seminomatous) Germ Cell Tumors Global Clinical Trials Review, H1, 2014" provides data on the Germinomatous (Seminomatous) Germ Cell Tumors clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Germinomatous (Seminomatous) Germ Cell Tumors. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe.

The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Germinomatous (Seminomatous) Germ Cell Tumors.

Scope

• Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
• Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
• Listings of discontinued trials (suspended, withdrawn and terminated)

Clinical Trial Overview of Top Institutes / Government

• National Cancer Institute
• European Organization for Research and Treatment of Cancer
• Children's Oncology Group
• The Royal Marsden NHS Foundation Trust
• Barts and The London NHS Trust
• Sheffield Teaching Hospitals NHS Foundation Trust
• Indiana University School of Medicine
• Abramson Cancer Center
• Medical Research Council
• Alberta Health Services

For more information visit http://www.researchandmarkets.com/research/zkbv4p/germinomatous